Emicizumab - Haemophilia

You are here : Home > Formulary Search > Emicizumab - Haemophilia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red

Formulations :

Not Specified

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

BNF SPC

NHSE

Restrictions / Comments :

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Emicizumab

Indication :

Haemophilia

Group Name :

Keywords :

clotting disorders, haemostatics, bleeding disorders

Brand Names Include :

Hemlibra

Important Information :

NHS England - specialist centres only

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Supporting Documents :

Other Indications

Below are listed other indications that Emicizumab is used to treat.

No records returned.

Other Drugs

Below are listed other drugs that are used to treat Haemophilia.

Committee Recommendations (1)

12 Nov 18 - Not Set

This drug / device falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.
Treatment should remain with the specialist (RED) hospital only drug.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication